Minimum Lumen Area Indexed to Left Ventricular Mass to Identify Functionally Significant Left Main Coronary Stenoses
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70026 ↗At a glance
Multizentrische Studie in Catheterization and Cardiovascular Interventions, 2025. Written by Giuseppe Patti and 12 co-authors. Institution: Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy. Major MEDLINE topics: Fractional Flow Reserve, Myocardial, Coronary Stenosis, Ultrasonography, Interventional, Coronary Vessels. Cited 1 times so far (Crossref); 17 references. The full text is freely available (open access, CC BY 4.0). Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background and Aim Diagnosing significant left main coronary artery (LMCA) stenoses based on anatomical criteria remains challenging. The ARMYDA FINISH multicenter study evaluated whether indexing intravascular ultrasound (IVUS)‐derived minimum lumen area (MLA) provides greater diagnostic accuracy than unindexed MLA for detecting hemodynamically significant LMCA stenoses, defined as a fractional flow reserve (FFR) ≤ 0.80.
Methods
Fifty‐two patients with angiographically‐intermediate isolated LMCA lesion were prospectively enrolled. All patients underwent IVUS and FFR measurements. Primary endpoint was the diagnostic accuracy of MLA indexed to height, body surface area (BSA), body mass index (BMI) and left ventricular (LV) echocardiographic mass in identifying hemodynamically significant LMCA stenoses compared to unindexed MLA. Secondary endpoints were the diagnostic sensitivity, specificity, and predictive values of indexed vs unindexed MLA cutoffs.
Results
Overall, 40 patients (77%) had FFR > 0.80 and 12 (23%) FFR ≤ 0.80. MLA indexed to LV mass achieved the highest area under the receiver operating characteristic curve (AUC = 0.91, 95% CI: 0.83–0.99; p < 0.001), compared to unindexed MLA (AUC = 0.86) and MLA indexed to height, BSA or BMI (AUC range = 0.84–0.85). At a cutoff of 29 mm 2 /kg for MLA/LV mass, sensitivity and negative predictive value (NPV) were both 100%, and specificity was 70%. All MLA thresholds (whether indexed and unindexed) exhibited low positive predictive value (PPV), ranging from 46% to 55%.
Conclusions
MLA/LV mass ratio may represent an accurate diagnostic tool for “ruling out” flow‐limiting LMCA lesions. Future large studies are needed to validate the MLA/LV mass ratio in diverse clinical settings and refine its cutoff values.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
- Division of Cardiology, Maggiore della Carità Hospital, Novara, Italy.
- Santi Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy.
- Vito Fazzi Hospital, Lecce, Italy.
ORCID profiles: Giuseppe Patti
Funding
- The authors received no specific funding for this work.
Cite
APA
Patti, G., Grisafi, L., Mennuni, M., Cumitini, L., Bosco, M., D'Amario, D., Solli, M., Rosso, R., Villa, M., Secco, G. G., Elia, E., Colonna, G., & Galiffa, V. (2025). Minimum Lumen Area Indexed to Left Ventricular Mass to Identify Functionally Significant Left Main Coronary Stenoses. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70026
Vancouver
Patti G, Grisafi L, Mennuni M, Cumitini L, Bosco M, D'Amario D, et al. Minimum Lumen Area Indexed to Left Ventricular Mass to Identify Functionally Significant Left Main Coronary Stenoses. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70026
BibTeX
@article{Patti2025,
author = {Patti, Giuseppe and Grisafi, Leonardo and Mennuni, Marco and Cumitini, Luca and Bosco, Manuel and D'Amario, Domenico and Solli, Martina and Rosso, Roberta and Villa, Matilde and Secco, Gioel Gabrio and Elia, Edoardo and Colonna, Giuseppe and Galiffa, Vincenzo},
title = {Minimum Lumen Area Indexed to Left Ventricular Mass to Identify Functionally Significant Left Main Coronary Stenoses},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70026}
}
EUVIMED